apolipoprotein E inhibitor

Apolipoprotein E (ApoE) inhibitors are a class of therapeutic agents designed to block the activity or expression of apolipoprotein E, a protein primarily known for its role in lipid metabolism and transport. In the context of oncology, specifically acute myeloid leukemia (AML), ApoE derived from the bone marrow microenvironment (mesenchymal stromal cells) has been identified as a promoter of disease progression. Research indicates that inhibiting ApoE can suppress leukemia cell growth, potentially by modulating MAPK signaling pathways. While ApoE is traditionally studied in the context of cardiovascular disease and Alzheimer's disease, its role in the tumor microenvironment represents an emerging area of therapeutic investigation for aggressive myeloid malignancies.

Other names

ApoE inhibitorapolipoprotein E inhibitors